Baptista-Honet al. described a decrease in metastatic potential of colon cancer cells (SW620 cells) by ropivacaine and decrease of Nav1.5 function (adult and neonatal isoforms)122. The gene discussed is SCN5A; the disease is colonic neoplasm.